These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 1863203)

  • 1. Platelet aggregation inhibiting and anticoagulant effects of oligoamines, XIV: Branched aliphatic and alicyclic triamines and tetramines.
    Rehse K; Kesselhut A; Schein V; Leissring S
    Arch Pharm (Weinheim); 1991 Apr; 324(4):243-7. PubMed ID: 1863203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet aggregation inhibiting and anticoagulant effects of oligoamines, XVII: Oligoamines with fluorescent properties. Part A: Fluorescent bridged nitrogen functions.
    Rehse K; Seidel T
    Arch Pharm (Weinheim); 1992 Apr; 325(4):235-9. PubMed ID: 1530456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antiaggregatory and anticoagulant effects of oligoamines. 12. Alkyl- and arylalkyl- derivatives of putrescine, spermidine and spermine].
    Rehse K; Puchert E; Leissring S
    Arch Pharm (Weinheim); 1990 May; 323(5):287-94. PubMed ID: 2383171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Anti-aggregatory and anticoagulant properties of oligoamines. 11. Oligoamines with two primary amine groups].
    Rehse K; Rose B; Leissring S
    Arch Pharm (Weinheim); 1990 Feb; 323(2):103-8. PubMed ID: 2334273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet aggregation inhibiting and anticoagulant effects of oligoamines, XVI: Cytostatic and cytotoxic side effects of oligoamines.
    Rehse K; Noack B; Maurer R; Hilgard P
    Arch Pharm (Weinheim); 1991 Oct; 324(10):797-801. PubMed ID: 1805711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet aggregation inhibiting and anticoagulant effects of oligoamines, XXI: 4,4'-Alkylene-bis-sydnone imines.
    Rehse K; Martens A
    Arch Pharm (Weinheim); 1993 May; 326(5):307-11. PubMed ID: 8328885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet aggregation inhibiting and anticoagulant effects of oligoamines, XIX: 4,4'-Phenylene-bis-sydnone imines.
    Rehse K; Kämpfe M; Martens A
    Arch Pharm (Weinheim); 1993 Mar; 326(3):163-6. PubMed ID: 8481095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet aggregation inhibiting and anticoagulant effects of oligoamines, XVIII: Oligoamines with fluorescent properties, Part B: Fluorophores in the molecular periphery.
    Rehse K; Seidel T
    Arch Pharm (Weinheim); 1994 Jun; 327(6):399-404. PubMed ID: 8048847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet aggregation inhibiting and anticoagulant effects of oligoamines, XXII: Bisoxazol-, bisimidazol-, bisthiazol- and oligo-1,2,4-thiadiazolimines.
    Rehse K; Martens A
    Arch Pharm (Weinheim); 1993 Jul; 326(7):399-404. PubMed ID: 8357302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antiaggregatory and anticoagulant effects of oligoamines. 10. Tertiary oligoamines and quaternary ammonium salts].
    Rehse K; Kämpfe M
    Arch Pharm (Weinheim); 1989 Nov; 322(11):811-5. PubMed ID: 2624527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet aggregation inhibiting and anticoagulant effects of oligoamines, XX: 4,4',4''-(1,3,5)-benzene-tris-sydnone imines.
    Rehse K; Martens A
    Arch Pharm (Weinheim); 1993 Apr; 326(4):217-9. PubMed ID: 8494483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antiaggregatory and anticoagulant effects of oligoamines. 5. Alicyclic di- and triamines].
    Rehse K; Carstensen A; Ernst HJ
    Arch Pharm (Weinheim); 1987 Sep; 320(9):829-36. PubMed ID: 3675171
    [No Abstract]   [Full Text] [Related]  

  • 13. [Anti-aggregation and anticoagulant effects of oligoamines. 3. M-phenylenebisaminoalkanes].
    Rehse K; Lükens U; Leissring S; Claus G
    Arch Pharm (Weinheim); 1987 Mar; 320(3):228-33. PubMed ID: 3579524
    [No Abstract]   [Full Text] [Related]  

  • 14. Platelet aggregation inhibiting and anticoagulant effects of oligoamines, XXVIII: Oligoamines with fluorescent properties. Part C: Fluorescent oligoamines with enhanced hydrophilic properties.
    Rehse K; Seidel T
    Arch Pharm (Weinheim); 1995 Feb; 328(2):131-5. PubMed ID: 7726738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antiaggregatory and anticoagulant effects of oligoamines. 7. Benzene-1,3,5-trialkaneamines].
    Rehse K; Lükens U; Claus G
    Arch Pharm (Weinheim); 1987 Dec; 320(12):1233-8. PubMed ID: 3439865
    [No Abstract]   [Full Text] [Related]  

  • 16. [Anti-aggregatory and anticoagulant effects of oligoamines. 6. Oligohydroxyalkane diamines].
    Rehse K; Claus G; Leissring S
    Arch Pharm (Weinheim); 1987 Nov; 320(11):1155-61. PubMed ID: 3439860
    [No Abstract]   [Full Text] [Related]  

  • 17. [Antiaggregative and anticoagulant effects of oligoamines. 8. Oligoamines with N-heterocyclic space structures].
    Rehse K; Mletzko S
    Arch Pharm (Weinheim); 1988 Sep; 321(9):533-6. PubMed ID: 3240067
    [No Abstract]   [Full Text] [Related]  

  • 18. Platelet aggregation inhibiting and anticoagulant effects of oligoamines, XXIII: Influence of the oligoamine RE 1492 on the deformability of red blood cells.
    Neumann M; Müller S; Grosse J; Lerche D; Rehse K
    Arch Pharm (Weinheim); 1994 Aug; 327(8):497-501. PubMed ID: 7944905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet aggregation inhibiting and anticoagulant effects of oligoamines, Part 33. From tetradecane- to octacosanediamines.
    Rehse K; Nolte-Driller R
    Arch Pharm (Weinheim); 1996 Apr; 329(4):191-6. PubMed ID: 8669983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Anti-aggregatory and anticoagulant effects of oligoamines. 9. The pharmacokinetics of N,N',N"-tris-4-(3-iodo-4-methoxyphenyl)-butyl-1,3,5-benzene triethanamine].
    Rehse K; Buck W; Wenzel M
    Arch Pharm (Weinheim); 1988 Nov; 321(11):813-6. PubMed ID: 3219050
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.